Previous close | 49.91 |
Open | 49.67 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's range | 49.19 - 49.75 |
52-week range | 40.38 - 51.30 |
Volume | |
Avg. volume | 796,841 |
Market cap | 11.226B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 24.77 |
EPS (TTM) | 1.99 |
Earnings date | 07 Feb 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.78 |
QIAGEN's (QGEN) latest launch is expected to aid the clinical diagnostics labs to boost their performance.
VENLO, The Netherlands, January 17, 2023--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for widescale use 18 months after being made available for research.
In this article we are going to estimate the intrinsic value of Qiagen N.V. ( NYSE:QGEN ) by taking the forecast future...